Sponsor

The Christie NHS Foundation Trust

Clinical research sponsor

Published trials36
Recruiting shown4
Roles2
SourceClinicalTrials.gov

Clinical trials

36 shown
A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)NCT05903430 · lead sponsor · 2025-08-29
RECRUITING
Chronic Radiation Induced Bowel Toxicity StudyNCT06640959 · lead sponsor · 2024-11-19
RECRUITING
Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the LungNCT07202260 · lead sponsor · 2025-07-03
ACTIVE_NOT_RECRUITING
A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerNCT04188119 · lead sponsor · 2023-12-01
WITHDRAWN
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNtsNCT04960059 · lead sponsor · 2022-02-11
COMPLETED
Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)NCT05702619 · lead sponsor · 2021-10-03
UNKNOWN
Lung Screening in People Cured of Hodgkin LymphomaNCT04986189 · lead sponsor · 2021-08-01
COMPLETED
Impact on Quality of Life From Multi-modality Lung CancerNCT04540757 · lead sponsor · 2020-11-25
UNKNOWN
Impact of COVID-19 on Lung Cancer PatientsNCT04538456 · lead sponsor · 2020-10-15
COMPLETED
Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative StudyNCT04396119 · lead sponsor · 2020-02-11
COMPLETED
A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerNCT03794596 · lead sponsor · 2019-09-01
WITHDRAWN
Personalised Disease Monitoring in Metastatic Breast CancerNCT04597580 · lead sponsor · 2019-05-08
ACTIVE_NOT_RECRUITING
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung CancerNCT03258788 · lead sponsor · 2019-01-03
COMPLETED
Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaNCT03837977 · lead sponsor · 2018-11-13
COMPLETED
Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer PatientsNCT03048760 · lead sponsor · 2017-09-11
COMPLETED
Respiratory Distress Symptom Intervention (RDSI) TrialNCT03223805 · lead sponsor · 2017-04-04
COMPLETED
Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple MyelomaNCT02275403 · lead sponsor · 2015-04-13
COMPLETED
Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate CancerNCT02424448 · lead sponsor · 2014-12-01
COMPLETED
The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility StudyNCT01842750 · lead sponsor · 2013-08-01
UNKNOWN
MEK Inhibitor and Thoracic Radiotherapy TrialNCT01146756 · lead sponsor · 2010-06-04
COMPLETED
Window Study of ZD4054 in Metastatic Prostate CancerNCT01168141 · lead sponsor · 2009-07-01
UNKNOWN
Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung CancerNCT00433563 · lead sponsor · 2008-04-01
COMPLETED
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerNCT00601406 · lead sponsor · 2006-03-01
UNKNOWN
Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinNCT00055965 · lead sponsor · 2002-11-01
UNKNOWN
Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT00022009 · lead sponsor · 2001-07-01
UNKNOWN
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryNCT00004887 · lead sponsor · 1999-01-01
UNKNOWN
Temozolomide in Treating Women With Advanced Breast CancerNCT00005054 · lead sponsor · 1998-05-01
UNKNOWN
Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLCNCT07718243 · collaborator · 2026-08-28
RECRUITING
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · collaborator · 2019-02-01
RECRUITING
Enhanced Monitoring for Better Recovery and Cancer Experience in Greater ManchesterNCT05099237 · collaborator · 2021-12-01
UNKNOWN
ARtificial Intelligence for Gross Tumour vOlume SegmentationNCT05775068 · collaborator · 2021-07-01
UNKNOWN
What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study ProtocolNCT04359420 · collaborator · 2019-08-01
COMPLETED
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant MesotheliomaNCT03654833 · collaborator · 2019-01-28
COMPLETED
The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver MetastasesNCT03562234 · collaborator · 2018-10-22
UNKNOWN
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.NCT03644303 · collaborator · 2018-08-13
COMPLETED
Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by SurgeryNCT00410683 · collaborator · 2007-02-01
UNKNOWN

Sponsor roles

lead sponsor27
collaborator9

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.